Zomedica (ZOMDF) EBITDA Margin (2021 - 2026)
Zomedica's EBITDA Margin came in at -16.17% for Q3 2026, up 41.96 percentage points from -58.13% a year earlier and up 7.38 percentage points from the prior quarter.
Powered by 
Analysis
Zomedica (ZOMDF) EBITDA Margin (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Zomedica reported EBITDA Margin of -26.11%, up 243.01 percentage points year-over-year; for FY2025, it was -238.53%, down 80.69 percentage points from FY2024.
- EBITDA Margin has declined in each of the last three years, though with a four-year change of +229.90 percentage points (FY2021 to FY2025).
- Going back by year, EBITDA Margin was -157.84% in FY2024 (-11.03 pp), -146.82% in FY2023 (-52.36 pp), -94.46% in FY2022 (+373.98 pp) and -468.43% in FY2021.
- The Q3 2026 figure represents the highest quarterly EBITDA Margin in data going back to Q1 2021.
- Year-over-year, EBITDA Margin has increased for six consecutive quarters, with an average year-over-year change of +96.63 percentage points over the last eight quarters.
- The fastest year-over-year change in EBITDA Margin over five years came in Q2 2022 (a gain of 32580.36 percentage points), and the weakest in Q1 2025 (a drop of 823.96 percentage points).
- Business Quant data shows ZOMDF's EBITDA Margin at -23.55% (Q2 2026), -34.20% (Q1 2026) and -31.02% (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 42.49% |
| 10 | Zomedica | 97.99 Mn | -87.03 Mn | 6.04 Mn | -16.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -16.17% |
| Jun 30, 2026 | -23.55% |
| Mar 31, 2026 | -34.20% |
| Dec 31, 2025 | -31.02% |
| Sep 30, 2025 | -58.13% |
| Jun 30, 2025 | -87.79% |
| Mar 31, 2025 | -958.98% |
| Dec 31, 2024 | -77.39% |
| Sep 30, 2024 | -77.35% |
| Jun 30, 2024 | -376.61% |
| Mar 31, 2024 | -135.02% |
| Dec 31, 2023 | -288.97% |
| Sep 30, 2023 | -68.57% |
| Jun 30, 2023 | -87.59% |
| Mar 31, 2023 | -112.17% |
| Dec 31, 2022 | -63.41% |
| Sep 30, 2022 | -113.86% |
| Jun 30, 2022 | -100.89% |
| Mar 31, 2022 | -73.53% |
| Dec 31, 2021 | -120.98% |
API Access
Zomedica EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ZOMDF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ZOMDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ZOMDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();